Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.35 |
| ▸ | TSHR | P16473 | 7/20 | 0.32 |
| ▸ | TP53 | P04637 | 4/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL28208586 | 0.96 | ALDH1A1 (0.32) | ALDH1A1TSHR | |
| Methacrylic Acid SCHEMBL27491190 | 0.96 | LMNA (0.39) | ALDH1A1TSHRLMNAHSD17B10 | |
| Methacrylic Acid SCHEMBL27682855 | 0.93 | ALDH1A1 (0.34) | ALDH1A1DGAT1 | |
| Methacrylic Acid SCHEMBL27682859 | 0.93 | TSHR (0.38) | ALDH1A1TSHRTP53HIF1ACYP3A4 | |
| Methacrylic Acid SCHEMBL27682861 | 0.89 | ALDH1A1 (0.50) | ALDH1A1TSHRDGAT1 | |
| SCHEMBL4610941 | 0.89 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53HIF1ACYP3A4 | |
| Acetic Acid SCHEMBL28197409 | 0.89 | ALDH1A1 (0.39) | ALDH1A1TSHRTP53HIF1ACYP3A4 | |
| Hydrogen Peroxide SCHEMBL27482921 | 0.89 | LMNA (0.38) | ALDH1A1TSHRTP53HIF1ACYP3A4 | |
| Acrylic Acid Ethyl Ester SCHEMBL564981 | 0.88 | TSHR (0.40) | ALDH1A1TSHRTP53HIF1ACYP3A4 | |
| SCHEMBL17728154 | 0.87 | TSHR (0.46) | ALDH1A1TSHRTP53HIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4431536-A1 | AQUEOUS CATIONIC POLYMER EMULSION AND AQUEOUS CATIONIC POLYMER EMULSION PREPARATION METHOD | CHT Turkey Kimya Sanayi ve Ticaret A.S. (TR) | 2024-09-18 | — | — | EP | disclosed |
| CN-107920985-A | Improved nano particle delivery system | 塞拉特药物股份有限公司 | 2018-04-17 | — | — | CN | disclosed |
| US-7951888-B2 | Block copolymer, composition comprising it and cosmetic treatment process | L'OREAL S.A. (FR) | 2011-05-31 | — | — | US | disclosed |
| CN-1997680-B | Sequenced copolymer | ARKEMA FRANCE | 2011-01-12 | — | — | CN | disclosed |
| CN-101707914-A | Resin composition | TEIJIN LTD | 2010-05-12 | — | — | CN | disclosed |
| US-20100055064-A1 | BLOCK COPOLYMER, COMPOSITION COMPRISING IT AND COSMETIC TREATMENT PROCESS | L'OREAL S.A. | 2010-03-04 | — | — | US | disclosed |
| US-7632905-B2 | Block copolymer, composition comprising it and cosmetic treatment process | L'OREAL S.A. (FR) | 2009-12-15 | — | — | US | disclosed |
| CN-101008782-A | Coating composition for photoresist | ROHM & HAAS ELECT MAT (US) | 2007-08-01 | — | — | CN | disclosed |
| CN-1997680-A | Sequenced copolymer | ARKEMA FRANCE (FR) | 2007-07-11 | — | — | CN | disclosed |
| US-20060030685-A1 | Block copolymer, composition comprising it and cosmetic treatment process | ARKEMA FRANCE (FR) | 2006-02-09 | — | — | US | disclosed |
| US-20010036979-A1 | Coloring composition, ink-jet ink and ink-jet recording method | FUJI PHOTO FILM CO., LTD. (JP) | 2001-11-01 | — | — | US | disclosed |
| US-5275847-A | Polymerizing an acrylic ester with a monomer containing hydroxyl groups; further polymerization with a monomer containing carboxyl groups; top coating | BASF LACKE+FARBEN AKTIENGESELLSCHAFT (DE) | 1994-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100055064-A1 | BLOCK COPOLYMER, COMPOSITION COMPRISING IT AND COSMETIC TREATMENT PROCESS | KRT18, DSG1, TPRKB | ALDH1A1 3163/4885TSHR 3376/4885TP53 267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.